ABSTRACT
INTRODUCTION: Previous studies suggest that quality improvement initiatives focused on hospital-acquired venous thromboembolism have a positive impact on prescribing rates of venous thromboembolism prophylaxis, especially those that incorporate computerized changes.
METHODS: We conducted a quality improvement project to determine whether education and computerized prescriber order entry system changes affect venous thromboembolism prophylaxis compliance rates in hospitalized medical patients at a Comprehensive Cancer Center. Between 1 January 2021 and 31 January 2023, 37,739 non-surgical, adult patient encounters with a length of stay > 48 h were analyzed in our study. From 18 December 2021 to 8 March 2022, provider education was delivered to the three largest admitting services, and computerized prescriber order entry changes were implemented incorporating a mandatory requirement to either order venous thromboembolism prophylaxis or document a contraindication for all patients at moderate venous thromboembolism risk.
RESULTS: Monthly venous thromboembolism prophylaxis compliance rates, as defined by the Centers for Medicare and Medicaid Services VTE-1 metric, increased from a mean of 74% to 93% after the interventions. This change was driven primarily by an increased utilization of mechanical venous thromboembolism prophylaxis from 37% to 53%.
CONCLUSION: Our study demonstrated that a multi-faceted intervention incorporating provider education and computerized prescriber order entry system changes can significantly increase venous thromboembolism prophylaxis compliance rates in cancer patients.
PMID:37801550 | DOI:10.1177/10781552231205779
12:58
PubMed articles on: Cancer & VTE/PE
12:58
PubMed articles on: Cancer & VTE/PE
A - 119 A Case Study: the Cognitive Functioning of an Adult Patient with Recurrent Craniopharyngiomas
12:58
PubMed articles on: Cardio-Oncology
12:58
PubMed articles on: Cancer & VTE/PE
12:58
PubMed articles on: Cancer & VTE/PE
Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea
12:58
PubMed articles on: Cancer & VTE/PE
12:58
PubMed articles on: Cardio-Oncology
12:58
PubMed articles on: Cancer & VTE/PE
Artificial intelligence in the prediction of venous thromboembolism: A systematic review and pooled analysis
12:58
PubMed articles on: Cardio-Oncology
12:58
PubMed articles on: Cancer & VTE/PE
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cardio-Oncology
12:59
PubMed articles on: Cancer & VTE/PE
Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry
12:59
PubMed articles on: Cancer & VTE/PE
Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study
12:59
PubMed articles on: Cancer & VTE/PE
17:07
Cardiotoxicity News
PubMed articles on: Cardio-Oncology
Irbesartan ameliorates inflammation via transendothelial leukocyte migration due to VCAM-1/NOX-1 signaling in cisplatin-induced cardiotoxicity
Iran J Basic Med Sci. 2023;26(11):1298-1304. doi: 10.22038/IJBMS.2023.70997.15422.
No comments:
Post a Comment
اكتب تعليق حول الموضوع